334 related articles for article (PubMed ID: 27102270)
1. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
Kador PF; Wyman M; Oates PJ
Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
[TBL] [Abstract][Full Text] [Related]
2. Topical composition for treating diabetic cataracts: a patent evaluation (WO2015026380A1).
Hao X; Han Z; Zhu C
Expert Opin Ther Pat; 2016 Jun; 26(6):731-5. PubMed ID: 26967920
[TBL] [Abstract][Full Text] [Related]
3. Does aldose reductase have a role in the development of the ocular complications of diabetes?
Lightman S
Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Kador PF; Kinoshita JH; Sharpless NE
J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
[No Abstract] [Full Text] [Related]
5. Aldose reductase inhibitors and diabetic complications.
Tomlinson DR; Willars GB; Carrington AL
Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
Cattalini M; Lerario AC
Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
[No Abstract] [Full Text] [Related]
7. NIH conference. Aldose reductase and complications of diabetes.
Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
[TBL] [Abstract][Full Text] [Related]
8. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
Huang Q; Liu Q; Ouyang D
Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
[TBL] [Abstract][Full Text] [Related]
9. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase: a window to the treatment of diabetic complications?
Crabbe MJ; Goode D
Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
[TBL] [Abstract][Full Text] [Related]
11. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
12. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
13. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
Brogard JM; Caro-Sampara F; Blicklé JF
Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
[TBL] [Abstract][Full Text] [Related]
14. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibitors as pathobiochemical probes.
Dvornik D
J Diabetes Complications; 1992; 6(1):25-34. PubMed ID: 1562755
[TBL] [Abstract][Full Text] [Related]
16. The role of aldose reductase inhibitors in diabetic complications: recent trends.
Kaul CL; Ramarao P
Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase inhibitors.
Kirchain WR; Rendell MS
Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
[TBL] [Abstract][Full Text] [Related]
18. Discoveries in research on diabetic keratopathy.
Cisarik-Fredenburg P
Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Drel VR; Pacher P; Ali TK; Shin J; Julius U; El-Remessy AB; Obrosova IG
Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitors and the complications of diabetes mellitus.
Tomlinson DR
Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
